Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
CALL
First Majestic Silver
AG
$9.07B
| $176K | ﹤0.01% |
43,900
+29,900
| +214% | +$152K |
|
4127
PUT
Itaú Unibanco
ITUB
$87.5B
| $176K | ﹤0.01% |
43,877
-41,656
| -49% | -$196K |
|
4128
Lesaka Technologies
LSAK
$420M
| $176K | ﹤0.01% |
9,768
-12,454
| -56% | -$188K |
|
4129
PUT
SiriusXM
SIRI
$10.1B
| $176K | ﹤0.01% |
5,870
+2,190
| +60% | +$84.9K |
|
|
ZNGA
4130
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $176K | ﹤0.01% |
88,100
+55,100
| +167% | +$154K |
|
4131
Jack Henry & Associates
JKHY
$11.1B
| $175K | ﹤0.01% |
2,738
-161,430
| -98% | -$10.7M |
|
4132
PUT
Pacira BioSciences
PCRX
$997M
| $175K | ﹤0.01% |
2,500
| – | – |
|
|
SGY
4133
CALL
DELISTED
Stone Energy
SGY
| $175K | ﹤0.01% |
257
+72
| +39% | +$61.2K |
|
4134
PUT
Lindsay Corp
LNN
$1.18B
| $174K | ﹤0.01% |
2,000
+1,500
| +300% | +$119K |
|
4135
PUT
Oxford Industries
OXM
$552M
| $174K | ﹤0.01% |
2,000
| – | – |
|
4136
PUT
ProShares VIX Short-Term Futures ETF
VIXY
$183M
| $174K | ﹤0.01% |
8
+7
| +700% | +$152K |
|
|
RDC
4137
DELISTED
Rowan Companies Plc
RDC
| $174K | ﹤0.01% |
8,266
-67,781
| -89% | -$1.43M |
|
|
DWA
4138
CALL
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $174K | ﹤0.01% |
6,700
-6,600
| -50% | -$173K |
|
4139
Trustmark
TRMK
$2.75B
| $173K | ﹤0.01% |
7,192
-2,825
| -28% | -$68.9K |
|
|
SRCL
4140
CALL
DELISTED
Stericycle Inc
SRCL
| $173K | ﹤0.01% |
1,300
-1,100
| -46% | -$151K |
|
|
CS
4141
DELISTED
Credit Suisse Group
CS
| $173K | ﹤0.01% |
6,459
-28,511
| -82% | -$771K |
|
|
GLUU
4142
CALL
DELISTED
Glu Mobile Inc.
GLUU
| $173K | ﹤0.01% |
28,800
-3,100
| -10% | -$19K |
|
|
ROSE
4143
PUT
DELISTED
ROSETTA RESOURCES INC
ROSE
| $173K | ﹤0.01% |
7,500
-3,300
| -31% | -$75.4K |
|
|
KKD
4144
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $173K | ﹤0.01% |
9,100
+7,112
| +358% | +$132K |
|
4145
PUT
Aecom
ACM
$9.75B
| $172K | ﹤0.01% |
5,200
+1,580
| +44% | +$52.1K |
|
4146
PUT
Chubb
CB
$135B
| $172K | ﹤0.01% |
1,700
-900
| -35% | -$96.9K |
|
4147
Mercado Libre
MELI
$92.3B
| $172K | ﹤0.01% |
1,220
+920
| +307% | +$130K |
|
|
CASC
4148
CALL
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $172K | ﹤0.01% |
9,533
+7,233
| +314% | +$114K |
|
|
TPLM
4149
DELISTED
Triangle Petroleum Corporation
TPLM
| $172K | ﹤0.01% |
34,466
+18,672
| +118% | +$100K |
|
|
4150
Pacira BioSciences
PCRX
$997M
| $171K | ﹤0.01% |
2,441
-788
| -24% | -$62.1K |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.